Your browser doesn't support javascript.
loading
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial.
Al Kaabi, Nawal; Zhang, Yuntao; Xia, Shengli; Yang, Yunkai; Al Qahtani, Manaf M; Abdulrazzaq, Najiba; Al Nusair, Majed; Hassany, Mohamed; Jawad, Jaleela S; Abdalla, Jehad; Hussein, Salah Eldin; Al Mazrouei, Shamma K; Al Karam, Maysoon; Li, Xinguo; Yang, Xuqin; Wang, Wei; Lai, Bonan; Chen, Wei; Huang, Shihe; Wang, Qian; Yang, Tian; Liu, Yang; Ma, Rui; Hussain, Zaidoon M; Khan, Tehmina; Saifuddin Fasihuddin, Mohammed; You, Wangyang; Xie, Zhiqiang; Zhao, Yuxiu; Jiang, Zhiwei; Zhao, Guoqing; Zhang, Yanbo; Mahmoud, Sally; ElTantawy, Islam; Xiao, Peng; Koshy, Ashish; Zaher, Walid Abbas; Wang, Hui; Duan, Kai; Pan, An; Yang, Xiaoming.
Afiliação
  • Al Kaabi N; Sheikh Khalifa Medical City, Abu Dhabi Health Services Company (SEHA), Abu Dhabi, United Arab Emirates.
  • Zhang Y; China National Biotec Group Company Limited, Beijing, China.
  • Xia S; Henan Province Center for Disease Control and Prevention, Zhengzhou, Henan, China.
  • Yang Y; China National Biotec Group Company Limited, Beijing, China.
  • Al Qahtani MM; Bahrain Defence Force Royal Medical Services, Military Hospital, Kingdom of Bahrain.
  • Abdulrazzaq N; Ministry of Health and Prevention, Abu Dhabi, United Arab Emirates.
  • Al Nusair M; Prince Hamza Hospital, Amman, Jordan.
  • Hassany M; Ministry of Health, Cairo, Egypt.
  • Jawad JS; Ministry of Health, Kingdom of Bahrain.
  • Abdalla J; Sheikh Khalifa Medical City, Abu Dhabi Health Services Company (SEHA), Abu Dhabi, United Arab Emirates.
  • Hussein SE; Sheikh Khalifa Medical City, Abu Dhabi Health Services Company (SEHA), Abu Dhabi, United Arab Emirates.
  • Al Mazrouei SK; Sheikh Khalifa Medical City, Abu Dhabi Health Services Company (SEHA), Abu Dhabi, United Arab Emirates.
  • Al Karam M; Sheikh Khalifa Medical City, Abu Dhabi Health Services Company (SEHA), Abu Dhabi, United Arab Emirates.
  • Li X; National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co, Ltd, Wuhan, Hubei, China.
  • Yang X; China National Biotec Group Company Limited, Beijing, China.
  • Wang W; Beijing Institute of Biological Products Co, Ltd, Beijing, China.
  • Lai B; China National Biotec Group Company Limited, Beijing, China.
  • Chen W; National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co, Ltd, Wuhan, Hubei, China.
  • Huang S; National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co, Ltd, Wuhan, Hubei, China.
  • Wang Q; China National Biotec Group Company Limited, Beijing, China.
  • Yang T; China National Biotec Group Company Limited, Beijing, China.
  • Liu Y; China National Biotec Group Company Limited, Beijing, China.
  • Ma R; Beijing Institute of Biological Products Co, Ltd, Beijing, China.
  • Hussain ZM; Sheikh Khalifa Medical City, Abu Dhabi Health Services Company (SEHA), Abu Dhabi, United Arab Emirates.
  • Khan T; Sheikh Khalifa Medical City, Abu Dhabi Health Services Company (SEHA), Abu Dhabi, United Arab Emirates.
  • Saifuddin Fasihuddin M; Sheikh Khalifa Medical City, Abu Dhabi Health Services Company (SEHA), Abu Dhabi, United Arab Emirates.
  • You W; Henan Province Center for Disease Control and Prevention, Zhengzhou, Henan, China.
  • Xie Z; Henan Province Center for Disease Control and Prevention, Zhengzhou, Henan, China.
  • Zhao Y; Beijing Institute of Biological Products Co, Ltd, Beijing, China.
  • Jiang Z; Beijing Key-Tech Statistical Consulting Co, Ltd, Beijing, China.
  • Zhao G; Beijing Key-Tech Statistical Consulting Co, Ltd, Beijing, China.
  • Zhang Y; Department of Epidemiology and Biostatistics, Ministry of Education Key Laboratory of Environment and Health and State Key Laboratory of Environmental Health (incubation), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Mahmoud S; G42 Healthcare, Abu Dhabi, United Arab Emirates.
  • ElTantawy I; G42 Healthcare, Abu Dhabi, United Arab Emirates.
  • Xiao P; G42 Healthcare, Abu Dhabi, United Arab Emirates.
  • Koshy A; Department of Epidemiology and Biostatistics, Ministry of Education Key Laboratory of Environment and Health and State Key Laboratory of Environmental Health (incubation), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Zaher WA; G42 Healthcare, Abu Dhabi, United Arab Emirates.
  • Wang H; Beijing Institute of Biological Products Co, Ltd, Beijing, China.
  • Duan K; National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co, Ltd, Wuhan, Hubei, China.
  • Pan A; Department of Epidemiology and Biostatistics, Ministry of Education Key Laboratory of Environment and Health and State Key Laboratory of Environmental Health (incubation), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Yang X; China National Biotec Group Company Limited, Beijing, China.
JAMA ; 326(1): 35-45, 2021 07 06.
Article em En | MEDLINE | ID: mdl-34037666
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunogenicidade da Vacina / Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: JAMA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Emirados Árabes Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunogenicidade da Vacina / Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: JAMA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Emirados Árabes Unidos